BIOMAT Database Logo BIOMAT Database Logo

Vancomycin-resistant enterococci osteomyelitis in the foot. A case report. 1997

A M Reyzelman, and C C Van Gils, and T C Hardin, and D J Vayser, and L B Harkless
Department of Orthopaedics, University of Texas Health Science Center, San Antonio, USA.

UI MeSH Term Description Entries
D008297 Male Males
D010019 Osteomyelitis INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA. Osteomyelitides
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013639 Tarsal Bones The seven bones which form the tarsus - namely, CALCANEUS; TALUS; cuboid, navicular, and the internal, middle, and external cuneiforms. Ankle Bones,Cuboid Bone,Cuneiform Bones,Navicular Bone of Foot,Tarsus Osseus,Os Naviculare,Bone, Cuboid,Bone, Cuneiform,Bone, Tarsal,Bones, Ankle,Bones, Cuboid,Bones, Cuneiform,Bones, Tarsal,Cuboid Bones,Cuneiform Bone,Foot Navicular Bone,Foot Navicular Bones,Naviculare, Os,Naviculares, Os,Os Naviculares,Tarsal Bone
D014640 Vancomycin Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. AB-Vancomycin,Diatracin,VANCO-cell,Vanco Azupharma,Vanco-saar,Vancocin,Vancocin HCl,Vancocine,Vancomicina Abbott,Vancomicina Chiesi,Vancomicina Combino Phar,Vancomicina Norman,Vancomycin Hexal,Vancomycin Hydrochloride,Vancomycin Lilly,Vancomycin Phosphate (1:2),Vancomycin Phosphate (1:2), Decahydrate,Vancomycin Sulfate,Vancomycin-ratiopharm,Vancomycine Dakota,Hydrochloride, Vancomycin,Sulfate, Vancomycin
D014769 Virginiamycin A cyclic polypeptide antibiotic complex from Streptomyces virginiae, S. loidensis, S. mitakaensis, S. pristina-spiralis, S. ostreogriseus, and others. It consists of 2 major components, VIRGINIAMYCIN FACTOR M1 and virginiamycin Factor S1. It is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry. Staphylomycin,Antibiotic 899,Eskalin,Founderguard,Stajac,Virgimycine
D016983 Enterococcus A genus of gram-positive, coccoid bacteria consisting of organisms causing variable hemolysis that are normal flora of the intestinal tract. Previously thought to be a member of the genus STREPTOCOCCUS, it is now recognized as a separate genus.

Related Publications

A M Reyzelman, and C C Van Gils, and T C Hardin, and D J Vayser, and L B Harkless
Vancomycin-resistant Enterococci infected puncture wound to the foot. A case report.
January 2000, Clinics in podiatric medicine and surgery,
A M Reyzelman, and C C Van Gils, and T C Hardin, and D J Vayser, and L B Harkless
Osteomyelitis attributable to vancomycin-resistant enterococci.
October 2002, Clinical orthopaedics and related research,
A M Reyzelman, and C C Van Gils, and T C Hardin, and D J Vayser, and L B Harkless
Vancomycin-resistant enterococci.
November 1995, Journal of cataract and refractive surgery,
A M Reyzelman, and C C Van Gils, and T C Hardin, and D J Vayser, and L B Harkless
Vancomycin-resistant enterococci.
October 1996, Clinics in podiatric medicine and surgery,
A M Reyzelman, and C C Van Gils, and T C Hardin, and D J Vayser, and L B Harkless
[Vancomycin-Resistant Enterococci].
November 2016, Rinsho byori. The Japanese journal of clinical pathology,
A M Reyzelman, and C C Van Gils, and T C Hardin, and D J Vayser, and L B Harkless
Vancomycin-resistant enterococci.
March 1997, The American journal of medicine,
A M Reyzelman, and C C Van Gils, and T C Hardin, and D J Vayser, and L B Harkless
Vancomycin-resistant enterococci.
May 1996, Postgraduate medicine,
A M Reyzelman, and C C Van Gils, and T C Hardin, and D J Vayser, and L B Harkless
[Vancomycin-resistant enterococci].
June 2018, Klinicka mikrobiologie a infekcni lekarstvi,
A M Reyzelman, and C C Van Gils, and T C Hardin, and D J Vayser, and L B Harkless
Vancomycin-resistant enterococci.
June 1996, The Annals of pharmacotherapy,
A M Reyzelman, and C C Van Gils, and T C Hardin, and D J Vayser, and L B Harkless
Vancomycin resistant enterococci.
August 1998, Burns : journal of the International Society for Burn Injuries,
Copied contents to your clipboard!